Literature DB >> 16529836

The use of recombinase mediated cassette exchange in retroviral vector producer cell lines: predictability and efficiency by transgene exchange.

A S Coroadinha1, R Schucht, L Gama-Norton, D Wirth, H Hauser, M J T Carrondo.   

Abstract

Currently, retroviral vector producer cell lines must be established for the production of each gene vector. This is done by transfection of a packaging cell line with the gene of interest. In order to find a high-titer retroviral vector producer clone, exhaustive clone screening is necessary, as the random integration of the transgene gives rise to different expression levels. We established a virus producing packaging cell line, the 293 FLEX, in which the viral vector is flanked by two different FRT sites and a selection trap. Using Flp recombinase mediated cassette exchange; this vector can be replaced by another compatible retroviral vector. The first step was the tagging of 293 cells with a lacZ reporter gene, which allowed screening and choosing a high expressing chromosomal locus. After checking that, a single copy of the construct was integrated, cassette exchangeability was confirmed with a reporter targeting construct. Subsequently gag-pol and GaLV envelope genes were stably transfected. The lacZ transgene was replaced by a GFP transgene and the 293 FLEX producer cell line maintained the titer, thus validating the flexibility and efficacy of this producer cell line. The tagged retroviral producer cell clone should constitute a highly advantageous cell line since it has a predictable titer and can be rapidly used for different therapeutic applications.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16529836     DOI: 10.1016/j.jbiotec.2006.01.037

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  13 in total

Review 1.  Cell culture processes for monoclonal antibody production.

Authors:  Feng Li; Natarajan Vijayasankaran; Amy Yijuan Shen; Robert Kiss; Ashraf Amanullah
Journal:  MAbs       Date:  2010-09-01       Impact factor: 5.857

2.  Recommended Method for Chromosome Exploitation: RMCE-based Cassette-exchange Systems in Animal Cell Biotechnology.

Authors:  André Oumard; Junhua Qiao; Thomas Jostock; Jiandong Li; Juergen Bode
Journal:  Cytotechnology       Date:  2006-06-14       Impact factor: 2.058

3.  Cell culture processes for the production of viral vectors for gene therapy purposes.

Authors:  James N Warnock; Otto-Wilhelm Merten; Mohamed Al-Rubeai
Journal:  Cytotechnology       Date:  2006-06-30       Impact factor: 2.058

4.  Single-step cloning-screening method: a new tool for developing and studying high-titer viral vector producer cells.

Authors:  A F Rodrigues; A S Formas-Oliveira; M R Guerreiro; H A Tomás; P M Alves; A S Coroadinha
Journal:  Gene Ther       Date:  2015-05-04       Impact factor: 5.250

5.  Use of the piggyBac transposon to create stable packaging cell lines for the production of clinical-grade self-inactivating γ-retroviral vectors.

Authors:  Steven A Feldman; Hui Xu; Mary A Black; Tristen S Park; Paul F Robbins; James N Kochenderfer; Richard A Morgan; Steven A Rosenberg
Journal:  Hum Gene Ther Methods       Date:  2014-08       Impact factor: 2.396

6.  Flexible pseudotyping of retrovirus using recombinase-mediated cassette exchange.

Authors:  Hugo R Soares; Ana I Almeida; Hélio A Tomás; Paula M Alves; Ana S Coroadinha
Journal:  Biotechnol Lett       Date:  2018-01-20       Impact factor: 2.461

7.  Recombinant protein expression by targeting pre-selected chromosomal loci.

Authors:  Kristina Nehlsen; Roland Schucht; Leonor da Gama-Norton; Wolfgang Krömer; Alexandra Baer; Aziz Cayli; Hansjörg Hauser; Dagmar Wirth
Journal:  BMC Biotechnol       Date:  2009-12-14       Impact factor: 2.563

8.  Impact of E1 and Cre on adenovirus vector amplification: developing MDCK CAV-2-E1 and E1-Cre transcomplementing cell lines.

Authors:  Paulo Fernandes; Virgínia M Santiago; Ana F Rodrigues; Hélio Tomás; Eric J Kremer; Paula M Alves; Ana S Coroadinha
Journal:  PLoS One       Date:  2013-04-02       Impact factor: 3.240

Review 9.  Production of lentiviral vectors.

Authors:  Otto-Wilhelm Merten; Matthias Hebben; Chiara Bovolenta
Journal:  Mol Ther Methods Clin Dev       Date:  2016-04-13       Impact factor: 6.698

10.  LentiPro26: novel stable cell lines for constitutive lentiviral vector production.

Authors:  H A Tomás; A F Rodrigues; M J T Carrondo; A S Coroadinha
Journal:  Sci Rep       Date:  2018-03-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.